-
GANT61 Workflows for GLI-Driven Cancer Research
2026-08-13
GANT61 is a practical GLI inhibitor for separating distal Hedgehog pathway activity from upstream signaling and testing GLI1/2-dependent tumor phenotypes. This guide connects dose-response experiments, immune-microenvironment assays, xenograft planning, and troubleshooting to the emerging role of GLI2 in immunotherapy resistance.
-
CAY10499: An Inhibitor of Human Hormone Sensitive Lipase
2026-08-13
CAY10499 gives lipid researchers a practical way to separate HSL- and MGL-dependent hydrolysis from upstream metabolic rewiring in monocytes, macrophages, adipocytes, and tumor models. Its strong recombinant-enzyme activity, limited cannabinoid-receptor displacement, and compatibility with DMSO-based workflows support mechanistic assay development rather than broad pathway speculation.
-
BBB Permeability Prediction with Lysosomal Correction
2026-08-12
Hu and colleagues developed a Transwell surrogate BBB platform based on LLC-PK1-MOCK and LLC-PK1-MDR1 cells, combining permeability and P-glycoprotein efflux measurements with a correction for lysosomal trapping. Its correlation with unbound brain distribution and improved interpretation of low-recovery compounds support its use for early CNS screening, while its surrogate nature warrants careful transferability assessment.
-
Machine Learning Discovery of Senolytics
2026-08-12
The reference study shows that cost-effective machine learning can extract useful senolytic predictions from small, heterogeneous published datasets rather than requiring large proprietary screens. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, providing a practical framework for early-stage senolytic discovery while highlighting the need for cell-type and senescence-context validation.
-
Tacrolimus (FK506): Applied Workflows and Troubleshooting
2026-08-11
Build reproducible calcineurin–NFAT experiments with Tacrolimus (FK506), from nanomolar cytokine assays to transplantation immunology research. This guide emphasizes solvent control, exposure design, genetic specificity controls, and practical translation into autoimmune disease models and tissue workflows.
-
MK-0812: Mapping CCR2 in Gut–Liver Inflammation
2026-08-11
MK-0812 provides a selective pharmacological lever for separating CCR2-dependent monocyte recruitment from gut-barrier and lipid-signaling mechanisms in MASH research. This article translates potency and whole-blood data into a practical, causally resolved assay strategy.
-
Dual Recombinase Tracing Finds No Postnatal Neo-oogenesis
2026-08-10
Xie, Zhou, and Zheng use complementary Cre-loxP and Dre-rox lineage tracing to test whether adult mouse ovaries generate new oocytes after birth. Across physiological aging and busulfan-induced injury, the study found no labeled growing oocytes or metaphase II eggs, strengthening the evidence against in vivo postnatal neo-oogenesis in mice.
-
Proteinase K for Fungal EV Assays
2026-08-09
Proteinase K is more than a routine DNA digestion reagent: it can help distinguish extracellular-vesicle surface proteins from protected cargo in Candida albicans studies. This article connects protease-protection assay design with recent evidence on EV-mediated NRG1 regulation and explains how to preserve interpretable molecular readouts.
-
Topological Stress, rDNA Lesions, and PML Compartments
2026-08-08
Urbancokova, Hornofova and colleagues show that topological stress and RNA polymerase I inhibition generate persistent ribosomal DNA lesions that drive PML-nucleolar association. Their combination of chemical stress, targeted I-PpoI cleavage, repair-pathway perturbation, and imaging links damaged rDNA to incomplete homologous recombination and subsequent senescence.
-
Central Circuits Behind Opioid Mechanical Hypersensitivity
2026-08-07
Yin et al. identify a lateral parabrachial-to-spinal opioid circuit that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study shows that MOR, dynorphin, KOR, and GABAergic neuron populations form a circuit-level gate for mechanical pain, providing a mechanistic framework for opioid receptor signaling research and chronic pain studies.
-
Actinomycin D: Next-Generation Transcriptional Inhibition In
2026-08-07
Explore how Actinomycin D enables advanced analysis of DNA damage response and transcriptional stress, with new insight into its mechanistic relevance for LLPS-based transcriptional regulation. Discover protocol optimizations and recent scientific breakthroughs bridging molecular biology and host-pathogen interaction research.
-
DAMGO and Central Circuits: Charting a New Era in Opioid Res
2026-08-06
This thought-leadership article bridges recent circuit-level findings on opioid-induced hypersensitivity with strategic insights for translational researchers. By dissecting DAMGO’s mechanistic precision as a µ-opioid receptor agonist, we outline how its use is redefining the experimental landscape of opioid receptor signaling research and chronic pain model development. Practical guidance is provided for protocol design, competitive positioning, and future directions—anchored in the latest evidence and APExBIO product intelligence.
-
Sulfo-Cy3 azide: Reliable Click Chemistry Labeling for Neuro
2026-08-06
This article addresses core workflow challenges in cell viability and birth dating assays, demonstrating how Sulfo-Cy3 azide (SKU A8127) delivers reproducible, high-sensitivity fluorescent labeling for demanding applications. Drawing on peer-reviewed evidence and practical use scenarios, we highlight how this bioconjugation reagent outperforms conventional dyes in water solubility, photostability, and workflow safety.
-
Host-Directed TB Therapy: GSK3 Inhibition as a Control Strat
2026-08-05
A recent iScience study demonstrates that inhibiting glycogen synthase kinase 3 (GSK3) in macrophages robustly controls the intracellular growth of Mycobacterium tuberculosis (Mtb). This host-directed approach, validated by both small-molecule inhibitors and genetic silencing, highlights a promising alternative to direct antimicrobials and broadens the landscape for multi-drug resistant tuberculosis treatment.
-
Cy3 NHS Ester (Non-Sulfonated): Technical Guide & QC Paramet
2026-08-05
Cy3 NHS ester (non-sulfonated) enables covalent fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides for sensitive detection in imaging and biochemical assays. It is recommended for workflows that tolerate organic co-solvents, but is not suitable for strictly aqueous protocols or for labeling highly sensitive proteins where co-solvent exposure must be avoided.